WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017175874) CANCER TREATMENT PHARMACEUTICAL COMPOSITION USING ANTI-MCT5 ANTIBODY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/175874 International Application No.: PCT/JP2017/014600
Publication Date: 12.10.2017 International Filing Date: 04.04.2017
IPC:
C12N 15/09 (2006.01) ,A61K 39/395 (2006.01) ,A61K 45/00 (2006.01) ,A61K 47/50 (2017.01) ,A61P 35/00 (2006.01) ,C07K 16/30 (2006.01) ,C12N 5/16 (2006.01)
Applicants: ORDER-MADE MEDICAL RESEARCH INC.[JP/JP]; 5-4-19, Kashiwanoha, Kashiwa-shi, Chiba 2770882, JP
Inventors: SATOFUKA, Hiroyuki; JP
OKABE, Youko; JP
KATO, Dai; JP
Agent: KOBAYASHI, Hiroshi; ABE, IKUBO & KATAYAMA, Fukuoka Bldg, 9th Fl., 8-7, Yaesu 2-chome, Chuo-ku, Tokyo 1040028, JP
Priority Data:
2016-07656506.04.2016JP
Title (EN) CANCER TREATMENT PHARMACEUTICAL COMPOSITION USING ANTI-MCT5 ANTIBODY
(FR) COMPOSITION MÉDICAMENTEUSE POUR TRAITEMENT DU CANCER METTANT EN ŒUVRE UN ANTICORPS ANTI-MCT5
(JA) 抗MCT5抗体を用いた癌治療用医薬組成物
Abstract:
(EN) The purpose of the present invention is to provide a novel pharmaceutical composition that is cancer-specific and has few side-effects. Provided by the present invention is a pharmaceutical composition containing a monoclonal antibody that recognizes a polypeptide in an extracellular region of native MCT5.
(FR) L'invention a pour objet de fournir une nouvelle composition médicamenteuse spécifiquement contre le cancer, et présentant peu d'effets secondaires. Plus précisément, l'invention concerne une composition médicamenteuse qui contient un anticorps monoclonal identifiant les polypeptides d'une région extracellulaire du MTC5 natif.
(JA) 本発明は癌特異的で副作用の少ない新たな医薬組成物の提供を目的とする。 本発明は、ネイティブなMCT5の細胞外領域のポリペプチドを認識するモノクローナル抗体を含む医薬組成物を提供する。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)